Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis - Wikidata - wikimedia - TriplyDB

Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis

Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis

http://www.wikidata.org/entity/Q21134808

about

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults Effect of Anti-TNF Antibodies on Clinical Response in Rheumatoid Arthritis Patients: A Meta-Analysis Regulation of immunotherapeutic products for cancer and FDA's role in product development and clinical evaluation TNF inhibitor therapy for rheumatoid arthritis Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt Comparative efficacy of biological agents in methotrexate-refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison.Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents.Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.Why is there persistent disease despite biologic therapy? Importance of early intervention A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoi Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment.The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter.Putative IL-10 Low Producer Genotypes Are Associated with a Favourable Etanercept Response in Patients with Rheumatoid Arthritis.Efficacy of etanercept for treating the active rheumatoid arthritis: an updated meta-analysis.Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysis.Insights into the role of progranulin in immunity, infection, and inflammation.3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation.Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetes.Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage.99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study Preferences of patients and health professionals for route and frequency of administration of biologic agents in the treatment of rheumatoid arthritis.The PIRO (predisposition, insult, response, organ dysfunction) model: toward a staging system for acute illness.Critical role of TNF-alpha-TNFR1 signaling in intracranial aneurysm formation.Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study.The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients.The problem of choice: current biologic agents and future prospects in RA.The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.Control of inflammatory heart disease by CD4+ T cells.Interleukin-1 antagonists for diabetes.Emerging therapies for rheumatoid arthritis.Skin toxicity of targeted cancer agents: mechanisms and intervention.Current immunotherapy in rheumatoid arthritis.Adalimumab in rheumatoid arthritis treatment: a systematic review and meta-analysis of randomized clinical trials.

P2860

Q24193535-3FD38EC3-18C9-4F57-916B-CF869ED714FA Q26739150-F4F0007E-14DB-479B-84DC-62B46AEAD418 Q27027876-4E344080-B559-4084-A658-309D79930910 Q28972424-4D1259FE-EDC3-4B45-BFE8-FFD2D164E56E Q30956564-84618957-7F62-420A-9159-3AFC5FBBA252 Q33690668-DD37256A-A498-4D6C-A08D-F294294FA9DA Q33726030-8BE13B0D-1F10-4F4B-BD18-70098B5824F6 Q33731716-CBFAA468-028F-469E-A42C-7ECF33446130 Q33778719-30EE9C3C-0668-4D7E-A4FE-45C3CBFDCCE8 Q33821890-5FDBC236-9957-4870-B06D-751BC972D257 Q33921820-D1C1F419-903C-485A-AA49-589B39578ACD Q34008773-0E499EB0-09FB-4C44-AFB3-645259E4EDE4 Q34858352-454C5197-3AB3-4E8B-ACE5-6FA7CFF1DAA0 Q35020811-ECB9370F-5B9E-4EC7-ACF9-07A24F01F820 Q35048301-09BC82A2-E537-414A-A9C3-A1249FB8CDD6 Q35154706-DC9ED865-EB85-49C5-B6E7-33E2383A64B1 Q35188042-651E8B7B-6DA9-4661-878D-17E55EFD224E Q35554857-F707FCF5-799E-47CA-AA3B-204F34C26DE5 Q35673147-321B3BE8-78D0-413D-9930-35CE42BF2ACA Q35768542-39F7B0BA-0FD7-4856-8828-D0F6B03ED95B Q36036975-87D426B1-F376-4042-89EB-383E2A4671DF Q36534831-26290D0F-4FCA-49AC-BF00-D67F119E4142 Q36727898-B1832A88-1505-4C24-8CFB-72351F25CAD8 Q36776326-86AD7912-5562-4011-81FF-F81A7F3E2479 Q37088215-E00EC2F7-69E6-4E52-B669-8403551C53C7 Q37340305-25BB4C3F-98D7-4EE7-8815-7BD18D3B9859 Q37494175-D2200689-2D38-4405-AE64-D70C455E870E Q37514466-FC6A4660-FE7D-4771-A541-B90696010C47 Q37563016-DF2C04ED-C120-4B79-B855-745F3732A12A Q37682327-DB504FE2-B258-408E-8B73-EB3F734835FE Q37697988-242863F3-DC10-43B4-82FF-20B552983BA9 Q37734085-3E7BB648-DB29-49CD-B96F-9CA1A3F5EA6A Q38082588-B15FD938-F9C2-41EE-AFE3-778C0094C568 Q38101877-0ECFF17D-0A52-4AC6-8219-AB5EF0551031 Q38108397-2391899F-3F20-4812-AEC5-88E8D2D48AB5 Q38109212-93276BA1-6337-496D-AF40-59B1B4AE962F Q38110963-9CF26E98-B612-45EE-BE7D-2661E461AAB3 Q38125504-83479E29-203F-4D45-BBB0-CE762A9320A8 Q38133655-D5F98C39-070F-4343-8042-94D77CE87694 Q38169508-40375A7F-14A7-4CC9-9831-99C941CB4942

P2860

Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis

http://www.wikidata.org/entity/Q21134808

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@ast

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@en

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@en-gb

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@nl

type

label

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@ast

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@en

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@en-gb

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@nl

altLabel

Systematic Review and Meta-Ana ...... atment of Rheumatoid Arthritis

@en

prefLabel

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@ast

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@en

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@en-gb

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@nl

P1433

Q21134808-F27F0C89-E057-4571-AE1E-FB28D12410C8

P1476

Q21134808-3CB2551B-BE85-4542-825A-AB05142B3576

P2093

Q21134808-135DC0EF-C8C5-43D6-A6DB-6B1AC5752471

Q21134808-555C7E3B-A7A3-4879-90D9-F8CAE7E01452

Q21134808-6BD2D198-67BF-4970-9AB5-6BBCD0959DF6

Q21134808-92417265-C726-4189-B093-22B6FE01614C

Q21134808-CFC94038-693D-49D7-97FE-946B5F76B20B

P275

Q21134808-53B74FC3-71F7-4994-80E3-D169D57C007F

P2860

Q21134808-03970E4D-1D85-4F69-B51B-3CD83961E7D9

Q21134808-03EB0BF5-F24D-4AA3-ADD0-781BBF154053

Q21134808-087A1255-8CDF-43C5-8D81-A766B7342AE5

Q21134808-0A235004-BC26-4461-B3DA-911189D34A53

Q21134808-0CC8910C-D7BB-41D7-A94A-6736C202099D

Q21134808-110C509E-C8CA-448F-8DD3-8A6BF2767E75

Q21134808-1138DD4E-19AE-481D-911C-C027D5E6A96A

Q21134808-13C4DA8D-75BD-4126-B77D-C8D69024CD7C

Q21134808-1B257AF7-A63A-4513-88A8-E25228E3FF0C

Q21134808-1D430DAE-5585-46DC-BD75-D9F68233A953

P304

Q21134808-D259C52E-0E2A-44CB-B8FA-533D7CAE7C48

P31

Q21134808-1814EAF9-9E62-4956-9113-BB8F46896F18

Q21134808-46246787-A198-4FB2-9000-1D29BEA8D3AE

Q21134808-8B83A699-B09D-48AD-BCEA-21BC14575570

Q21134808-E99EB7FF-DFA5-4C12-A23F-30AD2DE0A54E

P3181

Q21134808-6C955D57-C519-4C8A-A8B5-7ACEF0CEDF91

P356

Q21134808-23E489E5-DC6F-4D0B-93A7-5884CA9B12AC

P407

Q21134808-FD12FD3D-DBA6-43E7-9B3B-7FACF2AFF6AE

P433

Q21134808-64033F84-17A9-4F7D-BF5E-D830AB94E488

P478

Q21134808-503F70A2-67FA-49D6-A082-1B9EF631F04B

P50

Q21134808-A75988A1-3487-4EC5-BA0E-848CE8550D98

P5008

Q21134808-E38B3F50-B35D-4E08-BDD3-389A9C2F4C63

P577

Q21134808-2C5E65A2-3957-487E-8816-CB02F1578134

P5875

Q21134808-FBCE1254-CD9A-4BAE-8F4B-85F9E11CCFC4

P698

Q21134808-23711CD0-6642-47BD-9C59-B5EF1B723CEC

P921

Q21134808-562BDD42-375C-45FC-A687-B214C08A4B0A

Q21134808-D0A51780-2592-4E76-A791-740626DD9B23

Q21134808-D57A4FC7-B76F-41AB-9EAD-FB967B98BECF

Q21134808-DA53267D-E9D8-40A6-BE95-A1748F91F6C6

Q21134808-E125C056-6F17-48B6-836A-AD0E444B736F

Q21134808-E676E973-45BA-4975-A4ED-45191B555771

P932

Q21134808-79BB2C18-91E8-4D13-B385-8652637D5606

P3181

P356

JOURNAL.PONE.0030275

P1433

P1476

Systematic review and meta-ana ...... atment of rheumatoid arthritis

@en

P2093

Antti Malmivaara

http://www.w3.org/2001/XMLSchema#string

Dan C Nordström

http://www.w3.org/2001/XMLSchema#string

Kalle J Aaltonen

http://www.w3.org/2001/XMLSchema#string

Liisa M Virkki

http://www.w3.org/2001/XMLSchema#string

Marja Blom

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Biologics for rheumatoid arthritis: an overview of Cochrane reviews

Biologics for rheumatoid arthritis: an overview of Cochrane reviews

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins.

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety.

P304

e30275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

4215689

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0030275

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Yrjö Konttinen

P5008

P577

2012-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221772799

http://www.w3.org/2001/XMLSchema#string

P698

22272322

http://www.w3.org/2001/XMLSchema#string

P921

rheumatoid arthritis

Tumor necrosis factor

P932

3260264

http://www.w3.org/2001/XMLSchema#string